PRECIGEN, INC.

PGEN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $231.0M $190.9M $173.6M $71.9M $23.8M $13.8M $8.0M
Cost of Revenue $33.3M $37.7M $40.7M $11.0M $22.0K $0 —
Gross Profit $197.7M $153.2M $132.9M $60.9M $23.7M $13.8M —
Gross Margin 85.6% 80.2% 76.5% 84.7% 99.9% 100.0% —
Operating Expenses
Research & Development $143.2M $112.1M $147.5M $59.0M $48.1M $64.0M $70.2M
SG&A Expense $146.1M $142.3M $109.1M $63.6M $33.6M $24.9M $18.3M
Operating Income $-137.9M $-125.2M $-146.9M $-70.0M $-58.0M $-75.2M $-82.4M
Operating Margin -59.7% -65.6% -84.6% -97.3% -244.2% -545.6% -1,028.7%
Interest Expense $611.0K $861.0K $1.2M $666.0K $141.0K $57.0K $183.0K
Pretax Income $-78.4M $-194.2M $-87.0M $-85.7M $-40.9M $-81.9M —
Income Tax Expense $2.1M $-3.9M $1.0M $-103.0K $0 $0 $0
Net Income $-117.0M $-186.6M $-84.5M $-81.8M $-39.0M $-81.9M $-85.3M
Net Margin -50.7% -97.7% -48.7% -113.8% -164.1% -594.4% -1,064.3%
EPS (Basic) $-0.98 $-1.58 $-0.76 $-0.83 $-1.40 $-18.77 $-18.92
EPS (Diluted) $-0.98 $-1.58 $-0.76 $-0.83 $-1.40 $-18.77 $-18.92
Shares Outstanding (Basic) 122.1M 118.7M 116.7M 100.6M 97.1M 5.7M —
Shares Outstanding (Diluted) 122.1M 118.7M 116.7M 100.6M 97.1M 5.7M —
Dividends Per Share — — — — — — —
← Newer Page 2 of 2 Older →